Ivan Brukner, McGill University

Research

Drug Effect Infection Deseases Ivd Molecular Diagnostics Normalisation Personal Medicine Qpcr Quantification

Latest papers

The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward.
Journal of clinical microbiology · 2026 · first author
Extrachromosomal microDNA Signature as a Candidate Biomarker in Pediatric Acute Lymphoblastic Leukemia.
Cancer research communications · 2026 · first author
Assessing Different PCR Master Mixes for Ultrarapid DNA Amplification: Important Analytical Parameters.
Diagnostics (Basel, Switzerland) · 2024 · first author

All 19 publications

Latest funding

A new qPCR method for the assessment of total/relative bacterial load from stool samples: C difficile show case
CIHR · 2015 · Nominated PI
$131,513

All 1 grants and awards

19 publications.

01

The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward.

Brukner I, Oughton M

Journal of clinical microbiology2026First author

DOI: 10.1128/jcm.01788-25 PMID: 41954409

02

Extrachromosomal microDNA Signature as a Candidate Biomarker in Pediatric Acute Lymphoblastic Leukemia.

Brukner I, Gagné V, Richard-St-Hilaire A, Tremblay-Dauphinais P, Fuchs C, Bittencourt H, Veres T, Sinnett D, Krajinovic M

Cancer research communications2026First author

DOI: 10.1158/2767-9764.crc-25-0419 PMID: 41379638

03

Assessing Different PCR Master Mixes for Ultrarapid DNA Amplification: Important Analytical Parameters.

Brukner I, Paliouras M, Trifiro M, Bohbot M, Shamir D, Kirk AG

Diagnostics (Basel, Switzerland)2024First author

DOI: 10.3390/diagnostics14050477 PMID: 38472949

04

Pharmacogenetic Expression of CYP2C19 in a Pediatric Population.

Pierre-François MJD, Gagné V, Brukner I, Krajinovic M

Journal of personalized medicine2022

DOI: 10.3390/jpm12091383 PMID: 36143168

05

Importance of Adequate qPCR Controls in Infection Control.

Oughton M, Brukner I, Eintracht S, Papadakis AI, Spatz A, Resendes A

Diagnostics (Basel, Switzerland)2021

DOI: 10.3390/diagnostics11122373 PMID: 34943608

06

Sample Adequacy Control (SAC) Lowers False Negatives and Increases the Quality of Screening: Introduction of "Non-Competitive" SAC for qPCR Assays.

Brukner I, Resendes A, Eintracht S, Papadakis AI, Oughton M

Diagnostics (Basel, Switzerland)2021First author

DOI: 10.3390/diagnostics11071133 PMID: 34206413

07

A Fundamental Change in Antibiotic Susceptibility Testing Would Better Prevent Therapeutic Failure: From Individual to Population-Based Analysis.

Brukner I, Oughton M

Frontiers in microbiology2020First author

DOI: 10.3389/fmicb.2020.01820 PMID: 32973694

08

Maximizing confidence in a negative result: Quantitative sample adequacy control.

Brukner I, Eintracht S, Papadakis AI, Faucher D, Lamontagne B, Spatz A, Oughton M

Journal of infection and public health2020First author

DOI: 10.1016/j.jiph.2020.01.307 PMID: 32037201

09

Laboratory-developed test for detection of acute Clostridium difficile infections with the capacity for quantitative sample normalization.

Brukner I, Eintracht S, Forgetta V, Papadakis AI, Spatz A, Oughton M

Diagnostic microbiology and infectious disease2019First author

DOI: 10.1016/j.diagmicrobio.2019.04.017 PMID: 31176521

10

Rectal swab screening assays of public health importance in molecular diagnostics: Sample adequacy control.

Glisovic S, Eintracht S, Longtin Y, Oughton M, Brukner I

Journal of infection and public health2018Senior author

DOI: 10.1016/j.jiph.2017.07.009 PMID: 28801105

A new qPCR method for the assessment of total/relative bacterial load from stool samples: C difficile show case

Nominated PICIHR2015Proof of Principle Program - Phase I

Principal investigators: Brukner, Ivan

Keywords: Drug Effect; Infection Deseases; Ivd; Molecular Diagnostics; Normalisation; Personal Medicine; Qpcr; Quantification; Specifisity

$131,513

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Lady Davis Institute for Medical Research
Pharmacologie - Physiologie
Department of Laboratory Medicine and Pathobiology
Clinical Epidemiology
Other

Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Daniel Sinnett

Pharmacologie - Physiologie

4 shared papers, latest 2026

Paul Brassard

Clinical Epidemiology

1 shared papers, latest 2011

Ming-Sound Tsao

Department of Laboratory Medicine and Pathobiology

1 shared papers, latest 2008

Miltiadis Paliouras

Faculty

1 shared papers, latest 2024

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Drug Effect Dear Professor Brukner, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Ivan Brukner